BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer (Q42480323)
Jump to navigation
Jump to search
scientific article published on January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer |
scientific article published on January 2011 |
Statements
1 reference
BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer (English)
1 reference
John D Hainsworth
1 reference
Liang Fang
1 reference
Jane E Huang
1 reference
David Karlin
1 reference
Kenneth Russell
1 reference
Leonardo Faoro
1 reference
Christopher Azzoli
1 reference
1 January 2011
1 reference
1 reference
6
1 reference
1
1 reference
109-114
1 reference
Identifiers
1 reference
1 reference